PAK6 and chronic myelogenous leukemia, BCR-ABL1 positive: Indeed, PAK6 gene expression was significantly higher in CML compared to NBM (p = 0.0042) and in the microarray set of IM-nonresponders compared to IM-responders (p = 0.0264, Figure 1A) [20].